Valiant Organics Ltd
Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]
- Market Cap ₹ 1,338 Cr.
- Current Price ₹ 477
- High / Low ₹ 482 / 195
- Stock P/E 26.5
- Book Value ₹ 271
- Dividend Yield 0.00 %
- ROCE 5.47 %
- ROE 3.50 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of -0.43% over past five years.
- Company has a low return on equity of 0.50% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 692 | 675 | 755 | 1,153 | 1,052 | 723 | 719 | 739 | 766 | |
| 511 | 494 | 549 | 948 | 888 | 686 | 665 | 652 | 663 | |
| Operating Profit | 181 | 181 | 205 | 205 | 164 | 37 | 53 | 87 | 102 |
| OPM % | 26% | 27% | 27% | 18% | 16% | 5% | 7% | 12% | 13% |
| 8 | 6 | 6 | 7 | 13 | 6 | 9 | 13 | 23 | |
| Interest | 4 | 3 | 5 | 6 | 11 | 16 | 24 | 18 | 17 |
| Depreciation | 14 | 16 | 21 | 30 | 29 | 35 | 36 | 40 | 40 |
| Profit before tax | 171 | 168 | 185 | 176 | 137 | -9 | 2 | 42 | 68 |
| Tax % | 29% | 25% | 29% | 27% | 25% | -3% | 260% | 21% | |
| 121 | 126 | 131 | 128 | 103 | -8 | -3 | 33 | 54 | |
| EPS in Rs | 103.65 | 51.00 | 42.19 | 41.72 | 32.45 | -3.04 | -1.34 | 11.86 | 19.29 |
| Dividend Payout % | 6% | 11% | 12% | 8% | 3% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | -11% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -26% |
| 3 Years: | -33% |
| TTM: | 895% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -21% |
| 3 Years: | 1% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 1% |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 12 | 27 | 27 | 27 | 28 | 28 | 28 |
| Reserves | 254 | 374 | 475 | 586 | 662 | 702 | 697 | 731 |
| 77 | 140 | 209 | 364 | 274 | 257 | 249 | 256 | |
| 112 | 143 | 165 | 216 | 276 | 262 | 209 | 217 | |
| Total Liabilities | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,183 | 1,232 |
| 150 | 276 | 510 | 543 | 670 | 643 | 657 | 695 | |
| CWIP | 66 | 129 | 46 | 112 | 71 | 86 | 66 | 21 |
| Investments | 12 | 23 | 6 | 8 | 41 | 99 | 94 | 151 |
| 221 | 241 | 314 | 529 | 457 | 420 | 367 | 365 | |
| Total Assets | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,183 | 1,232 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 76 | 161 | 113 | -31 | 238 | 84 | 56 | 92 | |
| -86 | -184 | -156 | -124 | -143 | -65 | -21 | -86 | |
| 1 | 27 | 49 | 167 | -112 | -23 | -32 | -11 | |
| Net Cash Flow | -9 | 5 | 5 | 12 | -17 | -4 | 4 | -5 |
| Free Cash Flow | -13 | -44 | -58 | -153 | 108 | 19 | 27 | 59 |
| CFO/OP | 68% | 112% | 78% | 6% | 162% | 238% | 106% | 103% |
Ratios
Consolidated / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 72 | 76 | 102 | 88 | 106 | 90 | 120 |
| Inventory Days | 44 | 42 | 63 | 54 | 68 | 88 | 71 | 77 |
| Days Payable | 69 | 82 | 93 | 63 | 89 | 159 | 119 | 102 |
| Cash Conversion Cycle | 50 | 32 | 45 | 93 | 67 | 34 | 42 | 96 |
| Working Capital Days | 46 | 20 | -1 | 21 | 11 | -3 | -10 | 0 |
| ROCE % | 39% | 30% | 21% | 14% | 1% | 3% | 5% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Chlorination Sales Volume MT ・Standalone data |
|
|||||||
| Ammonolysis Sales Volume MT ・Standalone data |
||||||||
| Hydrogenation Sales Volume MT ・Standalone data |
||||||||
| Ammonolysis Plant Capacity (Vapi) MTPA ・Standalone data |
||||||||
| Chlorination Plant Capacity (Sarigam) MTPA ・Standalone data |
||||||||
| Hydrogenation Plant Capacity (Jhagadia Unit 1) MTPA ・Standalone data |
||||||||
| Total Production Capacity MTPA ・Standalone data |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement Under Regulation 30 - Receipt Rectification Order Under Income Tax Act, 1961
- Income-tax rectification order for AY2015-16; net payable Rs. 22,15,080.
-
Shareholder Meeting / Postal Ballot-Scrutinizers Report
- Valiant Organics disclosed 21st AGM voting results; all 15 resolutions passed with requisite majority.
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approves reappointment of Nemin Savadia, Santosh Vora, and MD Sathiababu Kallada for 3 years from May 24, 2027.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Presentation made to the shareholders at 21st Annual General Meeting of the Company.
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
Concalls
-
Aug 2026PPT
-
May 2026PPT
-
Feb 2026PPT
-
Nov 2025PPT
-
Sep 2025PPT
-
Aug 2025PPT
-
Jul 2025PPT
-
May 2025PPT
-
Feb 2025PPT
-
Dec 2024PPT
-
Aug 2024PPT
-
Jun 2024PPT
-
May 2024PPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023PPT
-
Nov 2022Transcript PPT
-
Nov 2022PPT
-
Sep 2022PPT
-
Aug 2022Transcript PPT
-
Jul 2022PPT
-
May 2022Transcript PPT
-
Mar 2022PPT
-
Mar 2022PPT
-
Feb 2022PPT
-
Sep 2021PPT
Business Overview:[1][2][3]
VOL is is promoted by Gogri, Chedda and Gala families. It manufactures specialty chemicals and is one of the largest manufacturers of chlorophenol derivatives, Benzene derivatives, PNA, PAP, Ortho Anisidine and Para Anisidine.
Product Portfolio[4]
1. Ammonolysis
Products include Para Nitro Aniline and Ortho Chloro Para Nitro Aniline, primarily serving the dyes and pigments industries.
2. Hydrogenation
The product range comprises Ortho Anisidine, Para Anisidine, IPPCA, Meta Chloro Aniline, Para Amino Phenol, and Ortho Amino Phenol, catering to dyes, pigments, pharmaceuticals, and agrochemicals sectors.
3. Chlorination
Key products are Para ChloroPhenol (PCP), Ortho ChloroPhenol (OCP), 2,4 Di ChloroPhenol (2,4 DCP), 2,6 Di ChloroPhenol (2,6 DCP), and 2,4,6 Tri ChloroPhenol (2,4,6 TCP), widely used in agrochemicals, cosmetics, veterinary, and pharmaceutical applications.